Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs.

Teixeira-Guedes, Catarina; Brás, Ana Rita; Teixeira, Ricardo G; Valente, Andreia; Preto, Ana

Teixeira-Guedes, Catarina; Brás, Ana Rita; Teixeira, Ricardo G; Valente, Andreia; Preto, Ana.

Afiliação

Teixeira-Guedes C; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Brás AR; Institute of Science and Innovation for Bio-Sustainability (IB-S), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Teixeira RG; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás dos Montes and Alto Douro, Quinta de Prados, 5000-801 Vila Real, Portugal.
Valente A; Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Preto A; Institute of Science and Innovation for Bio-Sustainability (IB-S), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

Pharmaceutics ; 14(6)2022 Jun 17.

Article em En | MEDLINE | ID: mdl-35745864

Palavras-chave

anti-colorectal cancer drugs; apoptosis; cell cycle arrest; cytoskeleton; ruthenium complexes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google